Publications of Martin Gengenbacher
All genres
Journal Article (21)
1.
Journal Article
2 (4), e00057-17 (2017)
Integration of Metabolomics and Transcriptomics Reveals a Complex Diet of Mycobacterium tuberculosis during Early Macrophage Infection. mSystems 2.
Journal Article
7 (1), 8853 (2017)
NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans. Scientific Reports 3.
Journal Article
47, pp. 8 - 16 (2017)
BCG — old workhorse, new skills. Current Opinion in Immunology 4.
Journal Article
7 (3), e00679-16 (2016)
Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis. mBio 5.
Journal Article
18 (5), pp. 364 - 368 (2016)
Post-exposure vaccination with the vaccine candidate Bacillus Calmette–Guérin ΔureC::hly induces superior protection in a mouse model of subclinical tuberculosis. Microbes and Infection 6.
Journal Article
18 (1), pp. 96 - 108 (2015)
Absolute Proteome Composition and Dynamics during Dormancy and Resuscitation of Mycobacterium tuberculosis. Cell Host & Microbe 7.
Journal Article
211 (11), pp. 1831 - 1841 (2015)
The Recombinant BCG ΔureC::hly Vaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation. The Journal of Infectious Diseases 8.
Journal Article
16 (1), 34 (2015)
Comprehensive insights into transcriptional adaptation of intracellular mycobacteria by microbe-enriched dual RNA sequencing. BMC Genomics 9.
Journal Article
210 (12), pp. 1928 - 1937 (2014)
Central Memory CD4+ T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC::hly Vaccine's Superior Protection Against Tuberculosis. The Journal of Infectious Diseases 10.
Journal Article
5 (3), e01262-14 (2014)
Dietary Pyridoxine Controls Efficacy of Vitamin B6-Auxotrophic Tuberculosis Vaccine Bacillus Calmette-Guérin ΔureC::hly Δpdx1 in Mice. mBio 11.
Journal Article
13 (5), pp. 619 - 630 (2014)
The BCG replacement vaccine VPM1002: from drawing board to clinical trial. Expert Review of Vaccines 12.
Journal Article
2 (2), MGM2-0020-2013 (2014)
Mycobacterium tuberculosis in the Proteomics Era. Microbiology Spectrum 13.
Journal Article
8 (11), e78966 (2013)
The Tuberculosis Vaccine Candidate Bacillus Calmette-Guérin ΔureC::hly Coexpressing Human Interleukin-7 or -18 Enhances Antigen-Specific T Cell Responses in Mice. PLoS One 14.
Journal Article
57 (10), pp. 4689 - 4698 (2013)
Improved Efficacy of Fosmidomycin against Plasmodium and Mycobacterium Species by Combination with the Cell-Penetrating Peptide Octaarginine. Antimicrobial Agents and Chemotherapy 15.
Journal Article
13 (5), pp. 602 - 612 (2013)
The Mtb Proteome Library: A Resource of Assays to Quantify the Complete Proteome of Mycobacterium tuberculosis. Cell Host & Microbe 16.
Journal Article
1 (2), pp. 120 - 138 (2013)
Nonclinical Development of BCG Replacement Vaccine Candidates. Vaccines 17.
Journal Article
57 (4), pp. 1648 - 1653 (2013)
Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 18.
Journal Article
23 (6), pp. 900 - 907 (2012)
Recombinant live vaccine candidates against tuberculosis. Current Opinion in Biotechnology 19.
Journal Article
36 (3 Sp. Iss. SI), pp. 514 - 532 (2012)
Mycobacterium tuberculosis: success through dormancy. FEMS MICROBIOLOGY REVIEWS 20.
Journal Article
56 (4), pp. 1735 - 1743 (2012)
Antigen 85C Inhibition Restricts Mycobacterium tuberculosis Growth through Disruption of Cord Factor Biosynthesis. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY